These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8581761)

  • 1. [Potential side-effects and interactions in multiple medication in elderly patients: methodology and results of the Berlin Study of Aging].
    Borchelt M
    Z Gerontol Geriatr; 1995; 28(6):420-8. PubMed ID: 8581761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug adverse effects in the elderly hospitalized with acute pathologies].
    Beltrami GC; Menegolli GP; Corrà L; Weber U; Longobardi A; Albiero A; Conati GF; Grezzana M; Vecchiato D; Fusi F; Grezzana LG
    Clin Ter; 2000; 151(1):19-23. PubMed ID: 10822877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital.
    Cruciol-Souza JM; Thomson JC
    J Pharm Pharm Sci; 2006; 9(3):427-33. PubMed ID: 17207423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.
    Gagne JJ; Maio V; Rabinowitz C
    J Clin Pharm Ther; 2008 Apr; 33(2):141-51. PubMed ID: 18315779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reactions in an elderly outpatient population.
    Schneider JK; Mion LC; Frengley JD
    Am J Hosp Pharm; 1992 Jan; 49(1):90-6. PubMed ID: 1570873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department.
    Hohl CM; Dankoff J; Colacone A; Afilalo M
    Ann Emerg Med; 2001 Dec; 38(6):666-71. PubMed ID: 11719747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentially harmful drug-drug interactions in the elderly: a review.
    Hines LE; Murphy JE
    Am J Geriatr Pharmacother; 2011 Dec; 9(6):364-77. PubMed ID: 22078863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication use in seniors: challenges and solutions.
    Tamblyn R
    Therapie; 1996; 51(3):269-82. PubMed ID: 8881121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Potential drug interactions in the treatment of elderly patients with multiple morbidity].
    Kruse W; Köhler J; Oster P; Schlierf G
    Z Gerontol; 1988; 21(3):164-8. PubMed ID: 3407287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prescription drugs and the elderly: results of the Argento study].
    Pizzuti R; Caffari B; Binkin N;
    Ig Sanita Pubbl; 2006; 62(1):11-26. PubMed ID: 17206165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
    Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug related hospital admissions in subspecialities of internal medicine.
    Hallas J
    Dan Med Bull; 1996 Apr; 43(2):141-55. PubMed ID: 8741207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring patient safety in ambulatory care: potential for identifying medical group drug-drug interaction rates using claims data.
    Solberg LI; Hurley JS; Roberts MH; Nelson WW; Frost FJ; Crain AL; Gunter MJ; Young LR
    Am J Manag Care; 2004 Nov; 10(11 Pt 1):753-9. PubMed ID: 15623265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use.
    Page RL; Ruscin JM
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):297-305. PubMed ID: 17296535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events.
    Ness J; Hoth A; Barnett MJ; Shorr RI; Kaboli PJ
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):42-51. PubMed ID: 16730620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of heart failure management in the elderly population.
    Cheng JW; Nayar M
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):233-49. PubMed ID: 19948300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reactions and drug interactions as causes of hospital admission in oncology.
    Miranda V; Fede A; Nobuo M; Ayres V; Giglio A; Miranda M; Riechelmann RP
    J Pain Symptom Manage; 2011 Sep; 42(3):342-53. PubMed ID: 21454043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential determinants of prescribers' drug-drug interaction knowledge.
    Ko Y; Malone DC; D'Agostino JV; Skrepnek GH; Armstrong EP; Brown M; Woosley RL
    Res Social Adm Pharm; 2008 Dec; 4(4):355-66. PubMed ID: 19064242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.